Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1

Area of Science:

• Oncology
• Molecular Biology
• Radiation Research

Background:

• MicroRNA-200c (miR-200c) is known to regulate epithelial-mesenchymal transition (EMT) and is inversely correlated with tumor progression.
• The role of miR-200c in radiation carcinogenesis, particularly in thymic lymphoma, remains largely unexplored.

Purpose of the Study:

• To investigate the expression and function of miR-200c in radiation-induced thymic lymphoma (RITL).
• To identify direct targets of miR-200c involved in RITL pathogenesis.
• To explore the therapeutic potential of modulating miR-200c in RITL.

Main Methods:

• Utilized a radiation-induced thymic lymphoma (RITL) mouse model.
• Assessed miR-200c expression levels in RITL samples.
• Employed miR-200c mimics and inhibitors to study its effects on lymphoma cells.
• Performed computational analysis and luciferase reporter assays to identify and validate miR-200c targets.
• Investigated the role of BMI1 as a downstream mediator of miR-200c.
• Evaluated the in vivo effect of miR-200c over-expression on tumorigenesis using an adenovirus vector.

Main Results:

• miR-200c was significantly downregulated in RITL samples.
• miR-200c mimic induced cell death and apoptosis in lymphoma cells, while an inhibitor decreased these effects.
• BMI1 was identified as a direct target of miR-200c, with its expression inversely correlated with miR-200c in RITL.
• Over-expression of BMI1 rescued the anti-lymphoma effects of miR-200c.
• Adenovirus-mediated over-expression of miR-200c reduced RITL tumor growth in vivo.

Conclusions:

• Downregulation of miR-200c and subsequent upregulation of its direct target BMI1 are key events in radiation-induced thymic lymphoma.
• Modulating miR-200c or inhibiting BMI1 presents a potential novel therapeutic strategy for RITL.